You are here: Industry Insights > Amneal

News List

Amneal Pharmaceuticals to buy majority stake in AvKARE for $340m pharmaceutical-technology
December 12, 2019
Amneal Pharmaceuticals has agreed to buy a 65.1% stake in pharmaceuticals manufacturer and wholesaler AvKARE and its affiliate R&S Northeast for approximately $340m.
Amneal Announces Approval of Generic Amicar americanpharmaceuticalreview
September 06, 2019
Amneal Pharmaceuticals has received approval from the U.S. Food and Drug Administration (FDA) for its generic version of Amicar® (aminocaproic acid oral solution) 0.25g/mL.
Could a 'creative deal' between Perrigo, Amneal help reinvent both struggling businesses? fiercepharma
August 22, 2019
With a spinoff for its prescription business on the ropes, Perrigo is treading water in its plans to reinvent its flagging business. Could a merger with another struggling drugmaker—à la Pfizer and Mylan—be the cure?
Alkermes Announces Settlement with Amneal over VIVITROL® Patent Dispute americanpharmaceuticalreview
July 31, 2019
Alkermes has entered into a settlement and license agreement with Amneal Pharmaceuticals to resolve Amneal's inter partes review (IPR) petition challenging U.S. Patent Number 7,919,499 ('499 Patent), an Orange Book-listed patent for ...
Amneal Announces Restructuring, Costs Savings Plan americanpharmaceuticalreview
July 11, 2019
Amneal Pharmaceuticals has announced a restructuring plan designed to reduce its cost base to and optimize its global manufacturing infrastructure. The company did not specify if the restructuring would include employee layoffs.
Zentiva buys Amneal subsidiary Creo Pharmaceuticals pharmaceutical-technology
April 23, 2019
Zentiva buys Amneal subsidiary Creo Pharmaceuticals.
Amneal Announces Approval of Rivastigmine Transdermal System americanpharmaceuticalreview
January 15, 2019
Amneal Pharmaceuticals has received FDA approval for a generic version of Exelon Patch (Rivastigmine Transdermal System), 4.6 mg/24 hours, 9.5 mg/24 hours, and 13.3 mg/24 hours.....
Amneal, JSP Enter Supply Agreement contractpharma
August 21, 2018
Amneal Pharmaceuticals announced a 10-year license and supply agreement for Levothyroxine sodium tablets with Jerome Stevens Pharmaceuticals, Inc. (JSP).......
Amneal Announces FDA Approval, Launch of Generic Welchol americanpharmaceuticalreview
May 18, 2018
Amneal Pharmaceuticals announced it has received final U.S. Food and Drug Administration (FDA) approval on its Abbreviated New Drug Application for a generic version of Welchol (colesevelam HCI) tablets, 625 mg.
Amneal to Close Hayward, California-Based Facilities, Operations americanpharmaceuticalreview
May 18, 2018
Amneal Pharmaceuticals announced actions to streamline operations as a result of the recent business combination with Impax Laboratories.

Previous page 1 2 3 Next page